Reference health
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
29/29 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 29 checked references that resolve
resolves10.1046/j.1526-4610.2001.041007646.x
Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
resolves10.1046/j.1468-2982.1996.1605310.x
Calcitonin Gene-Related Peptide is Released from Capsaicin-Sensitive Nerve Fibres and Induces Vasodilatation of Human Cerebral Arteries Concomitant with Activation of Adenylyl Cyclase
resolves10.1046/j.1468-2982.1997.1704518.x
Intravital Microscope Studies on the Effects of Neurokinin Agonists and Calcitonin Gene-Related Peptide on Dural Vessel Diameter in the Anaesthetized Rat
resolves10.1002/ana.410280213
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
resolves10.1038/sj.bjp.0703110
Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
resolves10.1016/S0028-3908(02)00008-4
Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment
resolves10.1002/sim.4780140909
AN EXTENSION OF THE CONTINUAL REASSESSMENT METHODS USING A PRELIMINARY UP‐AND‐DOWN DESIGN IN A DOSE FINDING STUDY IN CANCER PATIENTS, IN ORDER TO INVESTIGATE A GREATER RANGE OF DOSES
resolves10.1002/1531-8249(200002)47:2<238::AID-ANA15>3.0.CO;2-L
No acute antimigraine efficacy of CP-122,288, a highly potent inhibitor of neurogenic inflammation: Results of two randomized, double-blind, placebo-controlled clinical trials
resolves10.1046/j.1468-2982.2000.00117.x
Guidelines for Controlled Trials of Drugs in Migraine: Second Edition
resolves10.1046/j.1468-2982.2003.00528.x
Placebo Response in Clinical Randomized Trials of Analgesics in Migraine
resolves10.1016/0196-9781(92)90084-G
Distribution and effects of neuropeptide Y, vasoactive intestinal peptide, substance P, and calcitonin gene-related peptide in human middle meningeal arteries: Comparison with cerebral and temporal arteries
resolves10.1016/0304-3940(85)90296-4
Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: Trigeminal origin and co-existence with substance P
resolves10.1002/ana.410200409
Localization and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene–related peptide in human temporal arteries
resolves10.1002/ana.410230214
Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system
resolves10.1016/0143-4179(90)90114-E
Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides
resolves10.1016/0028-3908(91)90165-8
Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion
resolves10.1002/ana.410330109
The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats
resolves10.1046/j.1468-2982.1997.1704525.x
Sumatriptan Inhibits Neurogenic Vasodilation of Dural Blood Vessels in the Anaesthetized Rat—Intravital Microscope Studies
resolves10.1038/sj.bjp.0704842
Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene‐related peptide induced dilation of dural meningeal vessels
resolves10.1093/brain/120.12.2171
Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat
resolves10.1016/S0140-6736(01)06711-3
Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials
The 5 references without a DOI — listed, not checked
no DOI — not checkedEdvinsson L, Krause DN, eds. Cerebral blood flow and metabolism. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2002.
no DOI — not checkedr012
no DOI — not checkedr030
no DOI — not checkedr033
no DOI — not checkedr034
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1056/nejmoa030505"><img src="https://citestamp.com/citestamped/10.1056/nejmoa030505/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1056/nejmoa030505)